期刊名称：PEPTIDES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Peptides
|
Peptides is an international journal presenting original contributions on the chemistry, biochemistry, neurochemistry, endocrinology, gastroenterology, physiology, and pharmacology of peptides, as well as their neurological, psychological and behavioral effects. Peptides emphasizes all aspects of peptide research and covers investigations of these proteins in plants, insects, lower vertebrates, animals and clinical studies in humans. |
 |
Abstracting / Indexing
- BIOSIS
- Chemical Abstracts
- Current Contents/Life Sciences
- EMBASE
- Elsevier BIOBASE
- Index Medicus
- MEDLARS
|
- Medline
- Psych INFO, SciSearch, MEDLARS
- Reference Update
- Research Alert
- SCISEARCH
- Science Citation Index
|
Instructions to Authors
All manuscripts should be sent to Abba J. Kastin, Editor-in-Chief, 1601 Perdido Street, New Orleans, LA 70146, USA, Tel: (+1) 504 568 0811, Fax: (+1) 504 522 8559, E-mail: peptides@tulane.edu, for review and processing.
STYLE OF MANUSCRIPT
General Form. (1) All manuscripts should be submitted in triplicate and should be typewritten, double spaced with wide margins on good quality paper. If a word processor is utilized to prepare the manuscript, a letter quality printer must be used and computer generated illustrations must be of the same quality as professional line drawings or they will not be accepted. (2) The title page should contain: title of paper: author(s); laboratory or institution of origin with city, state, zip code, and country; complete address for mailing proofs, including telephone and FAX numbers and E-mail address, if available; a running head not to exceed 40 characters including spaces between words. (3) References, footnotes, and legends for illustrations should be typed on separate sheets, double spaced. (4) Illustrations (unmounted photographs) should be identified on the reverse with figure number and author(s) name; when necessary separate sheet and double spaced. (6) All dimensions and measurements must be specified in the metric system. (7) Italics should not be used for the purpose of emphasis. (8) Brief communications should be restricted to six typewritten pages, including references, and should not present more than one figure and one table, two figures, or two tables. (9) If you are submitting a manuscript in an area of research unfamiliar to most of our readers, something we encourage, please suggest possible referees.
Title. The title should not be longer than 85 characters, including spaces between words, and should contain the name of a specific peptide or the word "peptide(s)".
Length of Paper. The Editors insist upon clear, concise statement of facts and conclusions. Fragmentation of material into numerous short reports is discouraged.
Abstract. Each paper submitted must be accompanied by an abstract, which does not exceed 100 words and must be suitable for use by abstracting journals. The abstract should not end in a vague statement about the results being discussed.
A list of 3-12 words or short phrases suitable for indexing terms should be typed at the bottom of the abstract page accompanying the manuscript. These terms will be printed with the paper at the end of the abstract.
Drugs. Proprietary (trademarked) names should be capitalized. The chemical name should precede the trade, popular name, or abbreviation of a drug the first time it occurs.
Method. Analysis of variance followed by a multiple comparisons test is the appropriate statistical method for most comparisons. The F values should be reported in Results in the following form: F(11, 20) = 3.05, p  0.01. Student's t-test is not appropriate for multiple comparisons. The identity of immunoreactivity determined by RIA should be confirmed by HPLC.
Discussion. Do not include the obvious statement that further work is necessary or planned.
Amino Acids. The first letter of the 3-letter abbreviations for amino acids should be capitalized.
Footnotes. Title page footnotes should be numbered consecutively. If the senior author is not to receive reprint requests, a footnote should be given to designate to whom requests should be sent. Text footnotes should not be used: the material should be incorporated into the text. Table footnotes: see Tables (b).
References. Literature cited should be prepared according to the Numbered/Alphabetized style of the Council of Biology Editors. References should be cited by number, in parentheses, within the text (only one reference to a number) and listed in alphabetical order (double spaced) on a separate sheet at the end of the manuscript. Do not recite names of authors within the text. Journal citations in the reference list should contain the following: (a) surnames and initials of all authors (surname precedes initials); (b) title of article; (c) journal title abbreviated as listed in the List of Journals Indexed in Index Medicus; (d) volume, inclusive pages, and year. Example:
1. Van Dongen, P. A. M.; Theodorsson-Norheim, E.; Brodin, E.; Hökfelt, T.; Grillner, S.; Peters, A.; Cuello, A. C.; Forssmann, S.-G.; Reinecke, M.; Singer, E. A.; Lazarus, L. H. Immunohistochemical and chromatographic studies of peptides with tachykinin-like immunoreactivity in the central nervous system of the lamprey. Peptides 1986;7:297-313.
Book references should be in the following order: author, title, city of publication, publisher, year, and pages. Examples:
1. Mello, N. K. Behavioral studies of alcoholism. In: Kissin, B.; Begleiter, H., Eds. The biology of alcoholism, Vol. 2. Physiology and behavior. New York: Plenum Press; 1972:219-291.
2. Myers, R. D. Handbook of drug and chemical stimulation of the brain. New York: Van Nostrand Reinhold Company; 1974.
Computer disks. Authors are encouraged to submit a 3.5" HD/DD computer disk to the editorial office; 5.25"HD/DD disks are acceptable if 3.5"disks are unavailable. Please observe the following criteria: 1. Send only hard copy when first submitting your paper. 2. When your paper has been refereed, revised if necessary, and accepted, send a disk containing the final version with the final hard copy. Make sure that the disk and the hard copy match exactly (otherwise, the diskette version will prevail). 3. Specify what software was used, including which release, e.g., WordPerfect 6.0a. 4. Specify what computer was used (IBM-compatible PC, Apple Macintosh, etc.). 5. The article file should include all textual material (text, references, tables, figure captions, etc.) and separate illustration files, if available. 6. The file should follow the general instructions on style/arrangement and, in particular, the reference style of this journal as given in the Instructions to Authors. 7. The file should be single-spaced and should use the wrap-around end-of-line feature, i.e., returns at the end of paragraphs only. Place two returns after every element such as title, headings, paragraphs, figure and table call-outs. 8. Keep a backup disk for reference and safety.
Illustrations. (a) Prepare for use in a single column width whenever possible. (b) All drawings for reduction to a given size should be drawn and lettered to the same scale. (c) All illustrations should be referred to as figures and numbered in Arabic numerals. (d) Lettering should be done in India ink or other suitable material and must be proportionate to the size of the illustrations if it is to be legible after reduction. Lettering should be sized so that its smallest elements (subscripts or superscripts) will be readable when reduced. (e) When possible all lettering should be within the framework of the illustration; likewise the key to symbols should be on the face of the chart. The following standard symbols should be used as they are easily available to the printer:
- ,
 ,  , +, (f). Actual magnification of all photomicrographs should be given. Dimension scale should be indicated. (g) Sharply contrasting unmounted photographs of figures on glossy paper are required. (h) Illustrations should be submitted in black and white unless color reproduction is requested. Color prints should be submitted in actual size and authors will be responsible for the additional costs.
Tables. (a) Each table should have a brief heading; explanatory matter should be in footnotes, not as part of the title. (b) Table footnotes should be indicated in the body of the table in order of their appearance with the following symbols: * ? # ** etc. (c) Tables must not duplicate material in text or illustrations. (d) Vertical rules should be omitted. (e) Short or abbreviated column heads should be used. (f) Statistical measures of variation, SD, SE, etc., should be identified. (g) Analysis of Variance tables should not be submitted.
Formulas and equations. Structural chemical formulas, process flow-diagrams, and complicated mathematical expressions should be kept to a minimum. Usually chemical formulas and flow-diagrams should be drawn in India ink for reproduction as line cuts.
All subscripts, superscripts, Greek letters, and unusual characters must be clearly identified.
Anesthesia. In describing surgical procedures on animals, the type and dosage of the anesthetic agent should be specified. Curarizing agents are not anesthetics; if these were used, evidence must be provided that anesthesia of suitable grade and duration was employed.
Proofs. Corrections to the proofs must be restricted to printer's errors only. Other than these, any other alterations will be charged to the author.
Offprints. Each corresponding author will receive with the page proofs an offprint order form that must be completed and returned with the proofs. Authors of papers that significantly exceed average size (six printed pages) are requested to purchase 200 offprints of their article.
Publications are copyrighted for the protection of the authors and the publisher. A Transfer of Copyright Agreement will be sent to the author who submits the manuscript. The form must be completed and returned to the publisher before the article can be published.
Instructions regarding GenBank/DNA Sequence Linking:
DNA sequences and GenBank Accesion numbers: Many Elsevier journals cite "gene accession numbers" in their running text and footnotes. Gene accession numbers refer to genes or DNA sequences about which further information can be found in the database at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine. Elsevier authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources, should type this information in the following manner:
For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalised. (See Example 1 below). This combination of letters and format will enable Elsevier's typesetters to recognize the relevant texts as accession numbers and add the required link to GenBank's sequences.
Example 1: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)".
Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link.
In the final version of the printed article, the accession number text will not appear bold or underlined (see Example 2 below).
Example 2: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228, a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)".
In the final version of the electronic copy, the accession number text will be linked to the appropriate source in the NCBI databases enabling readers to go directly to that source from the article.
Editorial Board
Editor:
Abba J. Kastin, V A Medical Center, University of New Orleans and Tulane University School of Medicine, 1601 Perdido Street, New Orleans, LA 70146, USA Tel: +1 504 568 0811, Fax: +1 504 522 8559, Email: peptides@tulane.edu
Editorial Advisory Board:
A. Arimura, New Orleans, LA, USA
A. Balasubramaniam, Cincinnati, OH, USA
W.A. Banks, St. Louis, MO, USA
B.E. Beckwith, Ft. Myers, FL, USA
R.E. Carraway, Worcester, MA, USA
B.M. Chronwall, Kansas City, MO, USA
J.M. Conlon, Al-Ain, United Arab Emirates
D.H. Coy, New Orleans, LA, USA
T.P. Davis, Tucson, AZ, USA
L. Debeljuk, Carbondale, IL, USA
C. Denef, Leuven, Belgium
R.H. Ehrensing, New Orleans, LA, USA
R. Ekman, Moelndal, Sweden
F. Fuxe, Stockholm, Sweden
W.H. Gispen, Utrecht, The Netherlands
B. Göke, Munich, Germany
T. Hökfelt, Stockholm, Sweden
J.P. Houston, Düsseldorf, Germany
J.P. Huidobro-Toro, Santiago, Chile
H. Imura, Kyoto, Japan
A. Inui, Kobe, Japan
R.T. Jensen, Bethesda, MD, USA
S.P. Kalra, Gainesville, FL, USA
M. Massi, Camerino, Italy
S.M. McCann, Dallas, TX, USA
T.W. Moody, Rockville, MD, USA
J.E. Morley, St. Louis, MO, USA
R. J. Nachman, College Station, TX, USA
G.G. Nussdorfer, Padova, Italy
W. Pan, New Orleans, LA, USA
R. Quirion, Quebec, Canada
S.I. Rapoport, Baltimore, MD, USA
P. Robberecht, Brussells, Belgium
R.B. Rothman, Baltimore, MD, USA
S.I. Said, Stony Brook, NY, USA
C.A. Sandman, Orange, CA, USA
A.V. Schally, New Orleans, LA, USA
F. Strand, New York, NY, USA
Y. Tach?/B>, Los Angeles, CA, USA
K. Takahashi, Sendai, Japan
N. Tunçel, Eskisehir, Turkey
H. Vaudry, Mont-Saint-Aignan, France
M.J. Wayner, San Antonio, TX, USA
G. Williams, Liverpool, England
S. Yehuda, Ramat-gan, Israel
D.A. York, Baton Rouge, LA, USA
M. Yoshikawa, Kyoto, Japan
J. Zadina, New Orleans, LA, USA
|
